C-reactive protein and lipid parameters in older persons aged 80 years and older

Journal of Nutrition, Health and Aging

Volumn 13, Issue 7, 2009, Pages 587-594

  Cesari, Matteo ^a   Onder, G ^b   Zamboni, V ^b   Capoluongo, E ^b   Russo, A ^b   Bernabei, R ^b   Pahor, M ^a   Landi, F ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

C reactive protein; HDL cholesterol; LDL cholesterol; Total cholesterol

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

EID: 70349336904     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-009-0168-9     Document Type: Article

References (35)

1. Wilson PW, Anderson KM, Harris T, Kannel WB, Castelli WP. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J Gerontol 1994; 49(6):M252-M257. (Pubitemid 24354681)
2. Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005; 3:1618-1627. (Pubitemid 41716547)
3. Cesari M, Penninx BWJH, Newman AB, Kritchevsky SB, Nicklas BJ, Sutton-Tyrrell K et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108(19):2317-2322. (Pubitemid 37413536)
4. Reuben DB, Chen AI, Harris TB, Ferrucci L, Rowe JW, Tracy RP et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002; 50:638-644. (Pubitemid 34298751)
5. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003; 114(3):180-187. (Pubitemid 36294002)
6. Ferrucci L, Harris TB, Guralnik JM, Wacholder S, Tracy RP, Corti MC et al. Inflammation, a novel risk factor for disability in older persons. J Am Geriatr Soc 1999; 47:639-646.
7. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BWJH, Lenchik L et al. Sarcopenia, obesity and inflammation - Results from the TRAIN study. Am J Clin Nutr 2005; 82:428-434.
8. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med 2006; 119(6):526.e9-526.e17. (Pubitemid 43795180)
9. Abbott RD, Yano K, Hakim AA, Burchfiel CM, Sharp DS, Rodriguez BL et al. Changes in total and high-density lipoprotein cholesterol over 10- and 20-year periods (The Honolulu Heart Program). Am J Cardiol 1998; 82:172-178. (Pubitemid 28337727)
10. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004; 45(7):1169-1196. (Pubitemid 38802622)
11. Simons LA, Simons J, Friedlander Y, McCallum J. Cholesterol and other lipids predict coronary heart disease and ischaemic stroke in the elderly, but only in those below 70 years. Atherosclerosis 2001; 159(1):201-208. (Pubitemid 33016636)
12. Casiglia E, Palatini P. Cardiovascular risk factors in the elderly. J Hum Hypertens 1998; 12(9):575-581.
13. Landi F, Russo A, Cesari M, Barillaro C, Onder G, Zamboni V et al. The ilSIRENTE study: a prospective cohort study on persons aged 80 years and older living in a mountain community of Central Italy. Aging Clin Exp Res 2005; 17(6):486-493. (Pubitemid 46179353)
14. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice: a statement for healthcare professionals from the Center for Disease Control and Prevention and the American Heart Association. Circulation 2003; 177:499-511.
15. Morris JN, Fries BE, Bernabei R, Ikegami N, Gilgen R, Steel K et al. RAI - Home Care assessment manual. Washington, DC: InterRAI Coporation, 1996.
16. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist 1995; 35(2):172-178.
17. Landi F, Tua E, Onder G, Carrara B, Sgadari A, Rinaldi C et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000; 38(12):1184-1190.
18. Ferrucci L, Bandinelli S, Benvenuti E, Di Iorio A, Macchi C, Harris TB et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc 2000; 48:1618-1625.
19. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, Carbonin P. Drug data coding and analysis in epidemiologic studies. Eur J Clin Epidemiol 1994; 10:405-411. (Pubitemid 24339205)
20. Zuliani G, Volpato S, Ble' A, Bandinelli S, Corsi AM, Lauretani F et al. High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: The InChianti study. Atherosclerosis 2007; in press. (Pubitemid 46735937)
21. Ferrara A, Barrett-Connor E, Shan J. Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 1997; 96:37-43.
22. Volpato S, Zuliani G, Guralnik JM, Palmieri E, Fellin R, for the Gruppo Italiano di Farmacovigilanza nell'Anziano. The inverse association between age and cholesterol level among older patients: the role of poor health status. Gerontology 2001; 47:36-45.
23. Volpato S, Palmieri E, Fellin R, Zuliani G. Acute phase markers are associated with reduced plasma lipid levels in a population of hospitalized elderly patients. Gerontology 2000; 46(22):27. (Pubitemid 30006792)
24. Spieker LE, Ruschitzka F, Luscher TF, Noll G. HDL and inflammation in atherosclerosis. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4(1):51-57.
25. Ansell BJ, Fonarow GC, Fogelman AM. High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep 2006; 8(5):405-411.
26. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. Mechanisms of disease: proatherogenic HDL - An evolving field. Nat Clin Pract Endocrinol Metab 2006; 2(9):504-511. (Pubitemid 44353291)
27. Ferrucci L, Ble' A, Bandinelli S, Lauretani F, Suthers K, Guralnik JM. A flame burning within. Aging Clin Exp Res 2004; 16(3):240-243.
28. Lehtimäki T, Ojala P, Rontu R, Goebeler S, Karhunen PJ, Jylhä M et al. Interleukin-6 modulates plasma cholesterol and C-reactive protein concentrations in nonagenarians. J Am Geriatr Soc 2005; 53:1552-1558. (Pubitemid 41602446)
29. Kronmal RA, Cain KC, Ye Z, Ommen GS. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Arch Intern Med 1993; 153:1065-1073.
30. Newschaffer CJ, Bush TL, Hale WE. Aging and total cholesterol levels: cohort, period, and survivorship effects. Am J Epidemiol 1992; 136:23-24.
31. Hu P, Seeman TE, Harris TB, Reuben DB. Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur Studies of Successful Aging. J Am Geriatr Soc 2004; 51(1):80-84.
32. Karlamangla AS, Singer BH, Reuben DB, Seeman TE. Increases in serum non-high-density lipoprotein cholesterol may be beneficial in some high-functioning older adults: MacArthur Studies of Successful Aging. J Am Geriatr Soc 2004; 52(4):487-494.
33. Krumholz HM, Seeman TE, Merrill SS, Mendes de Leon CF, Vaccarino V, Silverman DI et al. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA 1994; 272(17):1135-1140. (Pubitemid 24323614)
34. Franceschi C, Bonafe' M, Valensin S, Olivieri F, De Luca M, Ottaviani E et al. Inflamm-aging - An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000; 908:244-254.
35. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105:1135-1143